| BIOARCTIC AB B |
| Schweden |
| Gesundheit |
| SE0010323311 / A2H5GS |
| B9A (Frankfurt) |
| FRA:B9A, ETR:B9A, B9A:GR |
| - |
| https://www.bioarctic.se/ |
|
BioArctic AB (publ) is a Swedish research-based biopharmaceutical company specializing in disease-modifying treatments for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS. Founded in 2003 by Professor Lars Lannfelt and Dr. PÃ..
>Volltext.. |
| 2550.04 Mio. EUR |
| 2377.98 Mio. EUR |
| 92.25 Mio. EUR |
| - |
| 9.71 Mio. EUR |
| 0.11 EUR |
| 8.34 Mio. EUR |
| 99.51 Mio. EUR |
| 22.45 Mio. EUR |
| 2.97 |
| -46.09% |
| -90.11% |
| 0.18 EUR |
| 0.63% |
| 0.63% |
| 29.05.26 - 0.18454€ 10.05.19 - 0.13599€ |
| - |
| BIOARCTIC |
| 02.11.26 |
|
||||
|